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Background: Although China experienced great improvement in their health system, disputes between patients
and doctors have increasingly intensified, reaching an unprecedented level. Retrospective analysis of medical
malpractice litigation can discover the characteristics and fundamental cause of these disagreements.
Methods: We analyzed medical malpractice litigation data from 1998 to 2011 for characteristics of claims via a
litigation database within a nationwide database of cases (1086 cases) in China, including claims, liabilities, injures,
and compensation payments.
Results: Among the cases analyzed, 76 percent of claims received compensation in civil judgment (640 out of 841),
while 93 percent were fault liability in paid judgment (597 out of 640). The average time span between the
occurrence of the injury dispute and closure of claims was 3 years. Twenty-two percent of claims (183 of 841) were
caused by injury, poisoning, and other external causes. Seventy-nine percent of claims (472 of 597) were contributed to
by errors in medical technology. The median damage compensation payment for death was significantly lower than
for serious injuries (P < 0.001; death, $13270 [IQR, $7617–$23181]; serious injury, $23721 [IQR, $10367–$57058]). Finally,
there was no statistically significant difference in the median mental compensation between minor injury, serious injury,
and death (P = 0.836).
Conclusion: The social reasons for the conflict and high payment were catastrophic out-of-pocket health-care expense
in addition to the high expectations for treatment in China. There were no distinguishing features between China and
other countries with respect to time of suits, facilities, and specialties in these claims. The compensation for damages in
different medical injuries was unfair in China.
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Although China has greatly improved on their health and
medicine system, disputes between patients and doctors
have increasingly intensified, reaching an unprecedented
level. Many factors contribute to the conflicts [1-3] be-
tween doctors and patients, including the high health care
costs, unreasonable prescription, [1] preventative medicine
[4], and unnecessary examinations [3]. Poor investment in* Correspondence: lihuafan@126.com
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China can lead to medical errors, corruption, and poor
communication between doctors and patients [5]. The
malpractice disputes occur both in China [6,7] and other
countries [8-11]. Beside eroding the trust [8] between pa-
tients and doctors, medical disputes and errors spawned a
great deal of economic loss [10]. Several studies have esti-
mated that approximately one RMB in malpractice com-
pensation may be an additional indirect cost leading to
hospital losses of 6.7 times more [12]. Though there have
been numerous reports or studies on malpractice in
China, studies seldom focus on malpractice litigation in
China. However, this may be due to the fact thathis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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available either in China or other countries.
In this study, we investigated the outcomes of malprac-
tice litigation according to structured retrospective reviews
of 1086 closed claims from 1998 to 2011 in China. Results
from our detailed analyses of patient claims could provide
valuable insights into malpractice litigation in China and
make significant contributions to both the safety of pa-
tients and management of litigation risk.
The malpractice laws in china
In China, there are three legislative regulations on
medical malpractice. The first is the Rule on the Hand-
ling of Medical Accident from 1987 to 2002. The sec-
ond is the Regulations on the Handling of Medical
Accident since 2002. The 2002 regulation replaces the
previous 1987 regulation and increases the adequacy
and fairness of compensation as well as the procedure
for resolving medical disputes [6]. The third regulation
is the Chapter Six Liability for Medical Malpractice of the
Tort Law of the People’s Republic of China, which was
adopted by the Standing Committee of the National
People’s Congress on December 26, 2009 and became
effective on July 1, 2010.
Methods
Study sites
We analyzed 1087 claims settled from February 1998 to
October 2011 in 29 provinces of China, using a medical
malpractice civil litigation database (civil ruling, civil
judgment, and civil mediation) from www.pkulaw.cn,
provided by ChinalawinfoCo. Ltd., Peking University
Center for Legal Information. The database is considered
of high authority and is distributed and used widely by
law professionals throughout China. More importantly,
it is admitted by the Supreme People’s Court of China
since 2003—Chinese Justice Legal Application Support
System (CJLASS) database. All 1086 closed claims in the
CJLASS database were allocated to “liability for medical
malpractice disputes”. Cases before 1998 were not thor-
oughly documented with all of the statistical information
needed for this study; thus, they were excluded from this
study. This study was designed to be a retrospective case
study. We intended to find out the characteristics of
medical malpractice litigants in China.
We are permitted to access to the database used in
our study by ChinalawinfoCo.Ltd. Our study had the
approval of the ethics committee of Harbin Medical
University of China.
Statistical analysis
The data sheets, which had been filled out by hand, were
electronically entered into a database and verified by a
professional data-entry vendor.We examined characteristics of the court, procedure,
appellant, type of medical facility in our samples, percent-
age of the medical specialties, classification of diseases, in-
jury, degree of liability, and concurrence of causes. We
reported the expense in litigation, amount of compensa-
tion paid, and days of litigation by using mean value and
confidence interval as well as the median and interquartile
range. We compared characteristics of errors and injuries,
using percentage agreement to determine the probability.
We used the Wilcoxon Rank-Sum test to study bivariate
associations of the liability, damage, and mental compen-
sation payment in medical malpractice litigation judg-
ment. Subsequently, analyses were conducted with the use
of the PASW Statistics software packages, version 18.0.
For our cross-sectional analysis, we limited our sample
to claims paid in 2011, because this was the most recent
year with complete data available. Hereafter, the amounts
shown are estimated based on $US 1 = ¥RMB 6.34.Criteria for coding and definition
Civil ligations have three results in China: “civil ruling”,
“civil judgment”, and “civil mediation in court”. A civil
ruling is the processing of a result of the procedure
problem and does not address the rights and obligations to
the defendant-plaintiff. Civil judgment is a verdict by the
judge about the malpractice dispute and addresses the
rights and obligations to the defendant-plaintiff. Civil medi-
ation is a compromise by the defendant-plaintiff in court.
Hospitals bear the liability in three ways: “liability for
breach of contract”, “fault liability”, and “equitable li-
ability”. Liability for breach of contract means that the
hospital undertakes the responsibility of a breach of
medical service contract with a patient. Fault liability
means that the hospital undertakes the liability based
on some degree of responsibility. Equitable liability
means that although the hospital is not at fault, it pro-
vides appropriate compensation for the injured patients
as per its current property status.
In our study, “type of medical facility” classified med-
ical facilities into 13 categories according to article three
of the Rules for the Implementation of the Regulations
on the Administration of Medical Institutions in China.
“Classification of diseases” classified diseases into 23 cat-
egories according to the International Statistical Classifica-
tion of Diseases and Related Health Problems 10th Revision
(ICD-10) used by the World Health Organization (WHO).
“Degree of liability” divided liability into five circum-
stances: “full liability” (hospital accepts 100% liability
for patient’s injury), “ultimate liability” (hospital ac-
cepts 50%–100% liability), “equal liability” (hospital ac-
cepts 50% liability), “secondary liability” (hospital
accepts 10%–50% liability), and “minor liability” (hos-
pital accepts <10% liability).
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rors contributed to the patient’s injury. Other causes
were “cause of patients and families”, “third person tort
and hospital joint infringement”, and “multiple medical
institutions joint infringement”.
“Medical error” was classified into “medical technology
error” (containing nine common subcategories, e.g., sur-
gery, drugs used, diagnose, treatment related errors, etc.),
“medical ethics error” (including infringement of patients’
informed consent or privacy), “medical product error”
(means the hospital used defective or unqualified blood
and blood products, medical equipment, and drugs, caus-
ing the injury), and “medical management error” (includ-
ing administrative, medical record-related, and risk-related
management errors).
We measured “injury” by combining the ten divisions
on the basis of disability levels, which were ruled on in
the Medical Accident Grading Standard in China (for
Trial Implementation), into four categories: “minor in-
jury” (injury below the six disability level; life cannot be
managed independently), “serious injury” (one to six dis-
ability level; most or part of life cannot be managed in-
dependently), “death”, and “emotional injury only”.
Results
Relationship between compensation and liability
Seventy-seven percent of the litigation cases fell into the
judgment category (Figure 1). Most claims receivedFigure 1 Overview of the relationship among malpractice disputes, jucompensation in judgment (640 of 841 [76 percent]) and in
mediation (90 of 91 [99 percent]). The outcomes of the
payment claims in judgment consisted of three types:
breach-of-contract liability (4 of 640 [0.6 percent]); fault li-
ability (597 of 640 [93 percent]), in which the liability was
based on some degree of responsibility; and equitable liabil-
ity (39 of 640 [6 percent]), in which there was a kind of dis-
tribution of responsibility and both parties thereto were
found to be without fault. Therefore, fault liability is the
dominant category in the majority of the claims.
Characteristics of claims
Seventy-four percent of the claims were solved by an
intermediate court (Table 1). Seventy-one percent were
closed after the second trial, and 22 percent were closed
after the first trial. In 78 percent of cases (n = 844), the
appellant—either hospital (31 percent), patient (56 per-
cent), or both (13 percent)—appealed the case.
Eighty-four percent of the claims were closed between
2006 and 2011, while 39 percent were closed in 2010 or
later. Eighty-three percent of the claims took place in
the midland and east of China. The average expense of
litigation per claim was $1224 (median, $804). The ex-
penses of plaintiff burden, on average, were nearly the
same as the defendants’ burden (roughly about $590
vs. $639). The average length of time between the occur-
rence of the injury dispute and closure of claims was
three years (median, two years).dicial records, outcomes of litigation and form of liability.
Table 1 Characteristics of 1086 Claims
Characteristic Characteristic
Court—no. (%) 1086 Others 26(3)
Inferior courts 230(21) Medical Specialties—no. (%)¶ 841
Intermediate court 803(74) Obstetrics and gynecology 162(19)
Superior court 53(5) Orthopedic 157(19)
Procedure—no. (%) 1086 General surgery 124(15)
The first trial 243(22) Neurology and neurosurgery 68(8)
Procedure of second Instance 766(71) Respiratory medicine 52(6)
Retrial process 78(7) Oncology 37(4)
Appellant—no. (%)* 844 Gastroenterology 36(4)
hospitals 265(31) Cardiology and cardiac surgery 35(4)
patients 468(56) Pediatrics 34(4)
both 110(13) Ophthalmology and otolaryngology 29(3)
Closure date—no. (%) 1086 Nephrology 18(2)
1998-2001 74(7) Urology 13(2)
2002-2005 104(9) Stomatology 10(1)
2006-2009 485(45) Others 66(8)
2010-2011 423(39) Classification of disease(ICD)—no. (%)‡ 841
Region—no. (%) 1086
The west 191(17) Injury, poisoning and certain other
consequences of external causes
183(22)
The midland 572(53)
The east 323(30) Pregnancy, childbirth and the puerperium 135(16)
Expense in litigation—$†‡ 932
Expense in litigation per-claim Diseases of the digestive system 92(11)
Mean 1224 Neoplasms 67(8)
Median 804 Diseases of the respiratory system 58(7)
Plaintiff burden Diseases of the nervous system 55(6)
Mean 590 Diseases of the circulatory system 53(6)
Median 295 Symptoms, signs and abnormal clinical and








Time of treatment Diseases of the genitourinary system 41(5)
Mean 41 Others 72(9)
Median 8 Degree of liability—no. (%)‖ 597
Time from treatment to discover the injury Full liability 172(29)
Ultimate liability 185(31)
Mean 311 Equal liability 38(6)
Median 5 Secondary liability 189(32)
Time from the dispute to closure Minor responsibility 13(2)
Mean 999 Concurrence of causes—no. (%)‖ 597
Median 758 Yes 447(75)
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Table 1 Characteristics of 1086 Claims (Continued)
Type of medical facility—no.(%)¶ 841 No 150(25)
General hospital 558(66) Types of concurrent causes— no. (%) 447
Township hospital 80(10)
Traditional Chinese Medicine Hospitals 52(6) Cause of patients and families 344(77)
The third person tort and hospital joint infringement 76(17)Specialty hospital 49(6)
Clinic 48(6) Multiple medical institutions joint infringement 27(6)
Maternal and Child Health Hospital 28(3)
*Percentage were calculated with the number of procedure of second instance (n=766) and retrial process(n=78).
†the case number of expense in litigation and time included the civil judgment (n=841) and civil mediation (n=91).
‡Value are given in 2011 dollars ($U.S.1=¥ 6.34).
¶Percentage were calculated with the number of the civil judgment (n=841).
‖Degree of liability and concurrence of tort were calculated on the basis of fault liability only (n=597).
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the patient in these cases (66 percent), followed by
township hospitals (10 percent) and traditional Chinese
medicine hospitals (6 percent). Disciplines such as ob-
stetrics and gynecology, orthopedics, and general surgery
accounted for the majority of medical specialties involved
in the medical malpractice claims (53 percent). Among
patients admitted to the hospital, 22 percent of issues were
caused by injury, poisoning, and certain other external
causes. Sixteen percent were due to pregnancy, childbirth,
and the puerperium (16 percent), while 11 percent were
caused by diseases of the digestive system.
Among the fault liability with pay claims (n = 597), 66
percent burdened the hospital with full, ultimate, or equal
liability. While 75 percent of the claims were concurrence
of causes for the injury (n = 447), 77 percent of the con-
current causes were between self-injury by patient or fam-
ily and hospital infringement for the injury. Secondarily,
17 percent of the concurrent causes were due to either the
third person tort or the hospital joint infringements. Fi-
nally, six percent of concurrent causes were due to joint
infringement by multiple medical institutions.
Contributing factors
There were four major factors contributing to the injuries:
medical technology error (79 percent), medical ethics
error (7 percent), medical product error (7 percent), and
medical management error (7 percent) (Table 2). Minor
injuries (44 percent) and death (34 percent) were the most
frequent outcomes in the malpractice claims. Serious in-
jury (20 percent) and emotional injury (2 percent) are the
secondary outcomes.
Compensation payment
There was no statistically significant difference in the
median compensation payments between the civil medi-
ation and the civil judgment groups (P = 0.125) (Table 3).
Similarly, there was no statistically significant difference
in the mental compensation payments between minor
injury, serious injury, and death groups (P = 0.836).Themedian liability compensation payment for fault liability
was significantly higher than that of equal liability
(P < 0.001; fault liability, $11611 [IQR, $5764–$24894];
equal liability, $2549 [IQR, $1087–$11376]).The me-
dian damage compensation payment for death was sig-
nificantly lower than that for serious injury (P < 0.001;
death, $13270 [IQR, $7617–$23181]; serious injury,
$23721 [IQR, $10367–$57058]). The maximum pay-
ment occurred in minor injury case, fault liability in civil
judgment ($628692). In 18 percent of claims (106 of 597),
no mental compensation was awarded for injury (minor
injury, n = 44; serious injury, n = 25; death, n = 37).
Discussion
Conflict between patient and doctor
Research data show that medical disputes increase from
year to year. There are a number of reasons for the increase
in doctor-patient conflict. With advances in healthcare-
related science and technology, patients have unrealistic
expectations about treatment, so the physician is more fre-
quently called to answer for any result falling short of pa-
tient expectations [10]. This is the common reason both in
China and other countries [13], like Italy [10].
In addition, due to poor investment and dramatic
marketization of the health system in China, Chinese pa-
tients generally spend more than half of their received
compensation from medical litigations on their medical
costs instead of receiving full coverage from their health
insurance companies.
As Liebman and Lancet report, families have had to pay
out of pocket up front for healthcare—a phenomenon re-
ferred to as “pay or die” [1] or “catastrophic expenses” [5]
in China. This special social issue worsens the relationship
between doctor and patient.
On the other hand, involved hospitals are also in an un-
fortunate situation, in which they have to cover expenses
for patients’ compensation from medical litigation. This is
in contrast with the situation in other countries in which
the cost is covered by medical liability insurance compan-
ies. In other words, both the patients and the hospitals
Table 2 Contributing factors associated with medical error by injury
Type of error Injury Total
Minor injury Serious injury Death Emotional injury only
Medical technology error 204 97 165 6 472(79%)
Surgery related 93 31 18 0 142(24%)
Drugs used related 25 11 45 1 82(14%)
Diagnose related 23 13 33 1 70(12%)
Treatment related 22 14 29 1 66(11%)
Pregnancy and delivery related 24 15 19 3 61(10%)
Infection related 6 5 6 0 17(3%)
Nursing related 2 3 10 0 15(2%)
Monitor related 5 3 4 0 12(2%)
Anesthesia related 4 2 1 0 7(1%)
Medical ethics error 19 8 10 3 40(7%)
Informant 18 7 10 3 38(6%)
Privacy 1 1 0 0 2(<1%)
Medical product error 28 8 4 3 43(7%)
Blood and blood products 11 4 3 2 20(3%)
Medical equipment 17 4 1 0 22(4%)
Drugs 0 0 0 1 1(<1%)
Medical management error 12 7 21 2 42(7%)
Administrative management 5 6 10 2 23(4%)
Medical record management 3 1 10 0 14(2%)
Risk management 4 0 1 0 5(<1%)
Total 263(44%) 120(20%) 200(34%) 14(2%) 597(100%)
Table 3 The compensation payment in medical malpractice litigation, 2011*
Compensation payment No. Mean (95% CI) Median (IQR) P Value†
Judgment
Civil mediation 90 $16493(11576-21409) $9108(4466-20482) 0.125
Civil judgment 640 $22508($19005-$26011) $11113($5315-$24049)
Liability
Equitable liability 39 $12002($2189-$21815) $2549($1087-$11376) <0.001
Fault liability 597 $23318($19621-$27014) $11611($5764-$24894)
Damage compensation
Minor injury 263 $15844($10806-$20882) $7632($3795-$17275) <0.001¶
Serious injury 120 $46662($33456-$59867) $23721($10367-$57058)
Death 200 $19565($16686-$22444) $13270($7617-$23181)
Mental compensation
Minor injury 263 $3606($2850-$4361) $1801($535-$4732) 0.836
Serious injury 120 $3159($2240-$4079) $1812($357-$4541)
Death 200 $3159($2587-$3730) $1869($340-$4492)
Abbreviation: CI confidence interval, IQR interquartile range, Max maximum, Min minimum.
*Value are given in 2011 dollars ($U.S.1 = ¥ 6.34).
†Wilcoxon Rank-Sum test for compensation payment.
¶Further Wilcoxon Rank-Sum test for damage compensation differences between minor injury, and serious injury(P < 0.001);As between serious injury and death
(P < 0.001),as between minor injury, and death (P < 0.001).
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disputes and become direct opposition parties.
Payment of malpractice claims
After comprehensive analysis of litigation data, we con-
cluded that the majority of claims were generally resolved
appropriately through medical malpractice litigation. When
combining payment claims for civil judgment and civil
mediation together, approximately two thirds of claims
(67 percent) resulted in payment. In addition, almost all of
the mediated claims in court resulted in compensation pay-
ment. However, only a small fraction of claims were solved
on monetary compensation without admission of errors
by hospitals.
Several previous studies in China and other countries
have investigated the outcomes of malpractice claims
[14-30]. Their findings vary widely, with 64 to 90 percent
of claims judged to result in financial compensation in
China [17,18] and about 25 to 65 percent of claims in
the USA [14-16] and other countries resulting in monet-
ary rewards. While informative, each of these Chinese
studies contains some flaws—for instance, use of smaller
numbers of claims (73 to 356 cases) [19,20] in the study
or narrow focus on a single hospital [19], area [21], or
specialty [22,31], and analysis of a single type of error
[23]. A similar situation existed in the USA [24-27,32],
England [28,29], Japan [30], and France [33]. In addition,
most of the Chinese studies did not address the issue of
compensation [19,20,22,23]. Our study was designed to
avoid these limitations and to conduct a comprehensive
analysis. In William B. Weeks’ study, researchers found
that financial compensation was made in 65 percent cases
[16]. David analyzed 1452 litigation claims and found that,
in 55 percent cases, patients received payment [15]. We
discovered that a similar proportion of claims (67 percent)
received financial compensation in our study. However, a
much lower percentage of cases were solved in settlement
in court (8 percent) than in William B. Weeks’ study
(61 percent). A low percentage of settlements indicates
the presence of more intense conflicts between patients
and hospitals in China.
The burden of malpractice litigation
We identified a small difference in the outcomes of liti-
gation for claims, specifically in the duration from the
dispute to closure of the litigation. On average, it takes
about two years [34] (three years in our study) in China
and five years [15] in the USA to complete a litigation,
which is longer than the time consumed in the cases of
settlement out of court (about 1 year both in China [34]
and the USA [16]). These periods are long for plaintiffs
to receive final decisions on monetary compensation
[15]. However, the prolonged litigation time was a rela-
tively small impacting factor for the defendants in China,where doctors are allowed to work in hospitals normally
during the period of litigation. This practice was quite dif-
ferent from that in the USA [15], where doctors involved
in lawsuits are not allowed to work during the litigation
period. Unfortunately, patients tend to resort to extreme
violence in medical disputes in China when they perceive
that doctors have poor attitude and lower quality of med-
ical services. Lenient punishments for doctors may par-
tially account for the violence in these medical disputes.
Reasons for high-risk medical specialties
Our results in type of medical facilities, medical specialties
in claims have few distinguishing characteristics compared
to other studies. The majority of malpractice disputes in
China occur in general hospitals and township hospitals
[35]. Obstetrics and gynecology, orthopedics, and general
surgery are always the top three medical-risk specialties,
both in China [12,17,20,34,35,36,37] and in the USA
[15,32]. Similar results were found in Taiwan that malprac-
tice experiences were more frequent in physicians of sur-
gery or obstetrics and gynecology [38]. This phenomenon
can be attributed to three factors. First, obstetrics and
gynecology deal with newborns or the female reproductive
system, and orthopedics handles body movement and work
competence. These tend to grab more attention from pa-
tients and their families [39]. Second, patients who are ad-
mitted to surgery departments often suffer from severe
diseases and expect dramatic improvements following a
major procedure. Third, surgical procedures are more dra-
matic and may encounter more risk than other specialties.
Diseases and liability in litigation cases
We found unexpected outcomes of disease and liability
in litigation cases. Injury, poisoning, and certain other
external causes were the main issues involved in these
claims. The majority of the patients’ injuries had concur-
rent infringement by other subjects, not only by one hos-
pital. In other words, these medical malpractice claims
occurred with greater complexity. In essence, there is no
guarantee of completely avoiding or preventing medical
risks in China. Furthermore, we found a stark difference
in the outcome of degree liability between those settled in
court and those settled out of court. The percentage of full
liability and ultimate liability was dramatically higher in
litigations settled in court (60 percent) than those resolved
out of court (8.4 percent) [20]. These results suggest that
secondary and minor liability claims are easy to reconcile
out of court.
Errors contribute to injuries
When analyzing the results of errors and injuries, we
found that the medical technology errors were certainly
the most frequent causes of injuries, rather than errors
of staff ethics or management of diseases. Nevertheless,
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city of medical documents in claims. In fact, some hospi-
tals may forge or change medical documents to cover up
their errors. Hospitals hold controlled access to patients’
records and, more often than not, deny patients access
to their own medical records. This does underline the
challenges in reality that a plaintiff faces when trying to
access and acquire evidential information that is crucial
for the proof of the claim [40]. In other words, this was
the deep-rooted reason for the “malpractice crisis” in
China: the lack of a credible system to deal with medical
malpractice and to solve related problems in quality of
medical care [6].
Unfair compensation in medical malpractice
We should pay attention to the unjust consequences of
various compensation payments for different injuries.
The average payment for serious injury ($23721) was
more than twice the payment made at death of a patient
($13270). In the Chinese compensation provisions, there
is stipulation on the disability compensation but no
provision on death compensation. The death compensa-
tion stipulation was only introduced in 2010 when the
Tort Liability Act, which was responsible for the lower
payment in the event of death, was introduced. Add-
itionally, the compensation for moral damages has been
legislatively limited or “capped” for plaintiffs in malprac-
tice cases by Chinese legal provisions for compensation
[1,41], which may be the reason for the similarity in com-
pensation among different injuries. These unreasonable
and unfair consequences can be mainly attributed to defi-
ciencies or flaws of medical malpractice law in China.
Limitations
We recognize that our study may contain the following
limitations. First, samples were drawn from a legal prece-
dent website involved in medical disputes. These samples
may not fully represent malpractice claims nationwide.
Other research reported that about 5.4 to 25.3 percent of
medical disputes were solved by litigation in all claims
[17,18,34,36,38]. Second, we do not have detailed informa-
tion on either doctors or patients involved in these litiga-
tion cases. Third, the practice of assigning categories in
our judgments may not be totally reliable, since arbitrary
assignment of categories may not fully represent the com-
plexity of malpractice claims. Fourth, we did not take the
liability factor into consideration when comparing com-
pensation amounts in different injuries.
Conclusion
The social reasons for the conflict and high payment
were catastrophic out-of-pocket health-care expense in
addition to the high expectations for treatment in China.
There were no distinguishing features between Chinaand other countries with respect to time of suits, facilities,
and specialties in these claims. The compensation for
damages in different medical injuries was unfair in China.
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